Johnson & Johnson’s target group is spread all over the world and has high demands on the quality of the content. The international biomedical company chooses webinars from Online Seminar to reach them. With success.
Johnson & Johnson develops medicines against a wide variety of illnesses, including in oncology, immunology and neuroscience. With 35,000 employees, the company is a major international player in the pharmaceutical sector. Like the company, the target group of doctors and health scientists is spread all over the world.
In order to reach them, webinars offer a profound solution. Webinars are interactive, can be viewed anywhere and on any device and remain accessible. Online Seminar has been Johnson & Johnson's exclusive partner since 2016. In total, Johnson & Johnson organises about 50 webinars a year.
A number of webinars take place on location during conferences. There, Johnson & Johnson offers a platform to share the most important scientific updates. Renowned doctors and other speakers share their vision and analysis. With the webinar functionalities such as polls and the chat, viewers can give their opinion. In addition, Johnson & Johnson organises webinars on other developments, such as the introduction of new medicines.